Objective: HIV-1 escape from cytotoxic T-lymphocytes results in the accumulation of human leucocyte antigen (HLA)-associated mutations in the viral genome. To understand the contribution of early escape to disease progression, this study investigated the evolution and pathogenic implications of cytotoxic T-lymphocyte escape in a cohort followed from infection for 5 years.
Introduction
HIV-1 subtype C-infected women in South Africa generally have rapid disease progression with more than 31% having CD4 þ cell count decline to less than 350 cell/ml in the first year of infection [1] . Under the current WHO treatment guidelines (CD4 þ cell count of <500 cells/ml), about 70% of these women would need to a go on therapy in the first year of infection [1] . Cytotoxic Tlymphocyte (CTL) responses, in particular Gag-targeted responses, are known to contribute to viral control in HIV-1 infections and drive the virus to escape through mutations [2] . The detrimental impact of immune evasion on pathogenesis can be alleviated in certain cases in which escape has a fitness cost on the virus [3] [4] [5] [6] [7] . Although it is known that clinical parameters in early infection are predictive of subsequent disease progression [1] , and it is well established that specific escape mutations restricted by protective human leucocyte antigen (HLA)-alleles [5, [7] [8] [9] [10] [11] can have a beneficial impact, less is understood at a population level how immune escape in early infection impacts long-term clinical outcome.
Protective HLA alleles, which generally target conserved epitopes, drive the evolution of CTL escape mutations which can attenuate viral replication resulting in slower disease progression [3, 5, 10, 12] . An HLA-independent study of 17 individuals, monitored from acute infection, found CTL escape occurred in all individuals within the first 50 days of infection [13] . The likelihood of escape was determined by a combination of the most dominant CTL response in an individual, together with the entropy of the target [13] . In this cohort of 17, escape in Gag was demonstrated in approximately 30% (n ¼ 5) of individuals [13] .
Several large cohort studies have demonstrated that CTL escape can be predicted on the basis of the HLA alleles expressed by the host [14] [15] [16] [17] [18] [19] . Furthermore, there is an inverse correlation between the potential breadth of HLA-mediated anti-Gag selection pressure, identified as the total number of potential HLA-associated sites, and viral loads [19, 20] . These studies have largely been done in chronic infection, and although it is known that events in the acute/early phase of infection are important predictors of disease progression [21] , there is limited information on the role of evolving HLA-associated polymorphisms during this critical period and their longterm impact on disease.
In this article, we report on a study of 78 individuals recruited within the first 3 months of infection, and followed for at least 5 years, or until CD4 þ cell count declined to less than 350 cells/ml. Taking advantage of well documented databases that have mapped HLAassociated polymorphisms in subtype C infection, we identified putative CTL escape mutations across the Gag protein in the first year of infection and investigated the impact on CD4 þ decline. The information reported here augments our understanding of mechanisms associated with rapid disease progression in this cohort. Understanding the extent of escape in early infection is also important to HIV-1 cure studies as it has been shown that these escape variants get archived and could potentially limit vaccine-associated interventions aimed at reducing the viral reservoir [22] .
Methods

Study participants
Participants in this study (n ¼ 78) were HIV-1-infected women from the CAPRISA 002 acute infection cohort [23] and the placebo arm of the CAPRISA 004 1% tenofovir gel microbicide trial [24] . We excluded participants from the treatment arm as there are ongoing studies to determine whether the 1% tenofovir gel resulted in selection of viruses with altered characteristics. We also excluded individuals who were dually infected (co-and super-infected) as well as those who were nonsubtype C infected. The CAPRISA 002 acute infection study was reviewed and approved by the research ethics committees of the University of KwaZulu-Natal (E013/04) and the University of Cape Town (025/2004). A written consent was obtained from all participants.
RNA isolation, reverse transcription-PCR and viral sequencing
The gag region was amplified and sequenced from plasma samples collected at enrolment (earliest available sample postinfection) and 12 months postinfection by nested reverse transcription-PCR as described previously [25] . RNA isolated from plasma samples using the Magna-Pure Compact Nucleic Acid Extractor (Roche, Branchburg, New Jersey, USA) was reverse transcribed using the Invitrogen Thermoscript Reverse transcription kit (Invitrogen, Carlsbad, California, USA) and the primer Gag D reverse (5 0 -AAT TCC TCC TAT CAT TTT TGG-3 0 ; HXB2 position 2382-2402). Limiting dilution nested PCR was carried out by serial end-point dilution of the cDNA [26] . The first round PCR primers for amplification were Gag D forward (5 0 -TCT CTA GCA GTG GCG CCC G-3 0 ; HXB position 626-644) and Gag D reverse. The second round PCR primers were Gag A forward (5 0 -CTC TCG ACG CAG GAC TCG GCT T-3 0 ; HXB2 position 683-704) and Gag C reverse (5 0 -TCT TCT AAT ACT GTA TCA TCT GC-3 0 ; HXB2 position 2334-2356). PCR products were sequenced using an ABI PRISM dye terminator cyclesequencing kit (Applied Biosystems, Foster City, California, USA) and the primers Gag A forward, Gag A reverse ( 0 ; HXB2 position 1748-1768) and Gag C reverse. Sequences were assembled using ChromasPro (www.technelysium.com.au/chromas.html).
For participants included in this study, the gag sequences from the enrolment and 12 months postinfection visits from each participant grouped together on a phylogenetic tree (data not shown).
Human leucocyte antigen typing High resolution (four digit) HLA typing was performed on all participants. DNA was extracted from either PBMCs or granulocytes using the Pel-Freez DNA Isolation kit (Pel-Freez, Rogers, Arizona, USA). HLA-A, HLA-B and HLA-C typing was performed by sequencing of exons 2, 3 and 4 using Atria HLAAlleleSeqr kits (Abbott, Chicago, Illinois, USA) or HLASBTexcellerator kits (Qiagen, Hilden, Germany) and Assign-SBT v3.5 software (Conexio Genomics, Fremantle, Australia). Any ambiguities resulting from either polymorphisms outside the sequenced exons or identical heterozygote combinations were resolved using sequence-specific primers or resolved statistically using the algorithm developed for this purpose [27] .
Identification of cytotoxic T-lymphocyte escape HLA-associated cytotoxic T-lymphocyte escape was determined by comparison of HLA-associated sites, derived from a large subtype C chronic infection dataset [16] , between enrolment and 12 months Gag amino acid sequences according to each participant's HLA genotype. The list of HLA-associated polymorphisms resulted from analysis of 2126 chronically HIV-1 subtype C-infected antiretroviral-naïve individuals from Southern Africa and found 301 polymorphisms in 90 epitopes [16] . Escape was defined as a change towards an HLA-adapted amino acid or away from a nonadapted amino acid [16] . In addition, mutations at HLA-associated sites which were neither going towards or away from adapted or nonadapted residues were also classified as escape. Plasma viral loads and CD4
þ cell counts at 12 months postinfection were calculated by taking the mean of three time-points closest to 12-month postinfection.
Statistical analyses
All statistical analyses were carried out in Graphpad Prism 5.0 (GraphPad Software, Inc., La Jolla, California, USA).
Results
A total of 78 HIV-1 subtype C-infected women were studied over a 5-year period, or until CD4 þ cell count decline to less than 350 cells/ml. The median (interquartile range) time postinfection for the earliest samples was 40 (26-54) days postinfection. At 12 months postinfection (set-point), the median log plasma viral load and CD4 þ cell count were 4.20 copies/ml and 432 cells/ml, respectively.
Escape was identified as changes in Gag amino acids sites between enrolment and 12 months postinfection at positions that have previously been shown to positively correlate with the participants HLA-alleles [16] . This list of HLA-associated polymorphism was derived from a chronic database, and it likely reflects both early and late escaping epitopes. We thus evaluated whether there was an association between the observed mutations and the total number expected based on the participants' HLA genotype. We found a significant association between the observed number of HLA-associated escape mutations and the HLA-associated polymorphisms over 12 months postinfection (Spearman r ¼ 0.3; P ¼ 0.03) (Fig. 1a) , supporting the use of this list for evaluation sequences from early infection.
Potential cytotoxic T-lymphocyte breadth in p24 associated with 12 months viral load set-point To determine if there was a relationship between the total potential CTL pressure that an individual exerts on the virus, and disease outcome, we calculated the total number of potential HLA-associated sites restricted by each participants HLA allele. We found no association between number of potential HLA-associated sites and either viral load or CD4 þ cell count for the entire Gag region or each of the Gag regions (p17, p24 and p7p6) (data not shown). However, there was a strong trend towards a negative association between the number of potential HLA-associated sites in p24 Gag and plasma viral load (Spearman r ¼ À0.2; P ¼ 0.07) (Fig. 1b) . This supports previous findings from acute and chronic infection [12, [28] [29] [30] and suggests that the CTL pressure on the conserved p24 Gag region contributed to early viral control.
Higher frequency of escape in more variable p17 Gag We then investigated actual escape across different Gag proteins (p17, p24 and p7p6). We identified HLAassociated escape mutations in the first year of infection in 48 (62%) study participants, with escape occurring in 1-5 sites per participant (Fig. 1c) . HLA-associated mutations occurred most frequently in p17 in 33 (42%) individuals, followed by escape in p24 in 22 (28%) individuals, and lastly in p7p6 in 14 (18%) individuals (Fig. 1c) . Twentythree per cent of the study participants harboured viruses that developed HLA-associated mutations only in p17, 16% only in p24 and 1% only in p7p6 ( Supplementary  Fig. 1 , http://links.lww.com/QAD/A997). Normalization of the number of HLA-associated mutations relative to the protein size further accentuated the differences in frequency between proteins with HLA-associated escape mutations per amino acid significantly higher in p17 compared with p24 (P ¼ 0.004) and p7p6 (P < 0.0001) (Fig. 1d) .
Early human leucocyte antigen-associated escape mutations predict CD4 R cell count decline to less than 350 ml/ml CTL escape in p24 has previously been reported to be beneficial in terms of lowering viral loads in early infection [5, 7] . We were interested in evaluating the relative impact of escape across all Gag proteins. We first compared the time with CD4 þ cell counts of less than 350 cells/ml in the first 5 years of infection for participants whose infecting viruses developed CTL escape and those where escape was not observed. The time to CD4 þ cell count decline less than 350 cells/ml was significantly shorter for participants whose infecting viruses developed CTL escape (P ¼ 0.05, log rank test) (Fig. 2a) . As escape in p24 tends to be associated with reduced viral load [5] [6] [7] , we stratified the HLA-associated escape mutations into p24 escape and p17/p7p6 escape (individuals in which HLA-associated escape mutations were observed in both p24, and variable regions were classified as p24 escape). Individuals whose viruses developed HLAassociated escape mutations in variable proteins (p17 and p7p6) progressed more rapidly to CD4 þ cell count decline to less than 350 cells/ml over 5 years, compared with those whose viruses developed p24 HLA-associated escape mutations [the order of progression; no escape more than p24 escape more than p17/p7p6 escape (P ¼ 0.03, log-rank test)] (Fig. 2b) . Significantly, of the 22 participants whose infecting viruses developed HLA-associated escape mutations in p24, only 11 (41%) had mutations at sites previously described to have a fitness cost to virus replication (HXB2 positions 146 [31] , 182 [32] and 242 [33] ) (Supplementary Table 1 , http://links.lww.com/ QAD/A997). This suggests that although CTL escape is associated with rapid CD4 þ decline, escape in the variables p17 and p7p6 proteins was more detrimental to disease progression than escape in the conserved p24 region.
HLA-associated escape in early infection is independent of plasma viral load As both viral load and CD4 þ cell count are predictors of disease progression, viral load is a potential confounder if the emergence of CTL escape mutations was driven by high viral loads. To interrogate this, we compared the plasma viral loads at 12 months postinfection between participants whose infecting viruses developed HLAassociated escape mutations (escape group) and those who did not (no-escape group). We found no differences in viral loads between the two groups (P ¼ 0.4) (data not shown). We also compared viral loads between the escape and no-escape groups at enrolment, 3 and 6 months postinfection and found no difference (P ¼ 0.3, 0.6 and 0.5, respectively) (data not shown). Repeating these analyses after removal of individuals with protective HLA alleles (HLA B Ã 57, B Ã 58 : 01 and B Ã 81; n ¼ 18) also showed no significant difference (P > 0.5) (data not shown). This suggests that the emergence of HLAassociated escape mutations in early infection was independent of viral load.
Impact of HLA-associated escape mutations on CD4
R decline is independent of protective HLA alleles As some HLA alleles are known to be protective and associated with slower disease progression, we investigated whether there was enrichment of protective HLA alleles (HLA B Ã 57, B Ã 58 : 01 and B Ã 81) in either group (escape and no escape). There was no significant difference in HLA alleles between the two groups [12/48 (25%) vs. 6/30 (20%), respectively; P ¼ 0.5; Fisher's exact test] (Fig. 3a) , and we found that protective HLA alleles were associated with a slower decline to CD4 þ cell counts of less than 350 cells/ml (P ¼ 0.02) (Fig. 3b) . Assessment of CD4 þ decline after excluding individuals with protective HLA alleles showed that individuals whose viruses developed HLA-associated escape mutations had rapid CD4 þ decline (P ¼ 0.05) (Fig. 3c) . We also observed that individuals whose viruses developed HLA-associated escape mutations in variable proteins (p17 and p7p6) progressed more rapidly to CD4 þ cell count decline to less than 350 cells/ml over 5 years, compared with those whose viruses developed p24 HLA-associated escape mutations [the order of progression; no escape more than p24 escape more than p17/p7p6 escape (P ¼ 0.05, log-rank test)] (Fig. 3d) . These results suggest that the effect of HLA-associated escape mutations on CD4 þ decline is independent of protective HLA alleles.
Discussion
To understand factors contributing to rapid disease progression observed in a subtype C cohort in South Africa [1] , we examined the impact of early CTL escape in Gag on disease progression. We detected a high frequency of HLA-associated escape mutations (48% of the study participants) which occurred predominantly in the p17 region (42% of participants). The development of HLA-associated escape mutations in the first year of infection was associated with a more rapid decline to CD4 þ cell count of less than 350 cells/ml, and the effect of escape was more pronounced for mutations occurring in the variable Gag proteins.
The breadth of CTL responses as well as targeting of conserved regions has been shown to be associated with viral control [12, 28, 29] . We reasoned that the number of HLA-associated escape sites for each individual is a measure of the potential CTL pressure that the individual exerts on the virus. We found a trend towards a negative association between the total potential number of HLAassociated escape sites and plasma viral load at 12 months postinfection (Spearman r ¼ À0.2; P ¼ 0.07) for p24 Gag. This underscores the importance of CTL responses targeting the functionally and structurally conserved p24 region and supports previous findings from chronic subtype B infections [20] .
Previous studies have reported specific immune escape mutations in p24 Gag that are associated with partial attenuation of viral replicative fitness and slower disease progression [5, 7, 8] . In this study, participants in whom HLA-associated escape mutations developed in the first year of infection progressed faster to CD4 þ cell count less than 350 cells/ml compared with those where HLAassociated escape mutations were not detected (P ¼ 0.05). However, individuals whose viruses escaped in the more variable p17/p7p6 regions progressed faster to CD4 þ cell count less than 350 cells/ml compared with those in which HLA-associated escape mutations were observed in the more conserved p24. These results suggest that although overall CTL escape is detrimental to the host, escape in the variable regions of the virus (p17 and p7p6) is associated with a more rapid CD4 þ decline.
We found protective HLA alleles to be evenly distributed between individuals whose viruses developed escape mutations and those who did not (P ¼ 0.5, Fisher's exact test), and participants with protective HLA alleles had slower CD4 þ decline. Significantly, the association between HLA-associated escape mutations and CD4 þ decline was robust to the exclusion of participants with protective HLA alleles. These data suggest that protective HLA alleles were not a major driver of the observed impact of HLA-associated escape mutations on CD4 þ decline. Significantly, although viral load is also correlated with CD4
þ decline, the emergence of HLA-associated escape mutations in the first year of infection was not associated with plasma viral load, suggesting that CTL escape, independent of other disease progression makers, can predict CD4 þ decline.
In this study, we have assessed the impact of HLAassociated escape mutations in the first year on CD4 þ decline in the first 5 years of infection and showed that putative HLA-associated escape mutations are associated with a shorter time to CD4 þ cell count decline to less than 350 cells/ml, which is more pronounced in the variable Gag regions (p17 and p7p6) compared with the conserved p24. The high frequency of early putative escape may be a contributing factor disease progression in HIV-infected South Africans.
